Bangalore, India -- (SBWIRE) -- 10/26/2017 -- Immunoglobulins are glycoprotein molecules produced by plasma cells. They are a critical part of a body's immune response and they do so by specifically recognizing and binding to microbes and destroying them. These immunoglobulins are produced by a body naturally, but due to some genetic or infectious diseases, the natural production of immunoglobulin is inhibited, resulting in an immune-compromised condition.

Report forecast the global intravenous immunoglobulins market to grow at a CAGR of 7.62% during the period 2017-2021.

The report covers the present scenario and the growth prospects of the global intravenous immunoglobulins market for 2017-2021. To calculate the market size, the report considers sales from both generic and branded drugs.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Global Intravenous Immunoglobulins Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- CSL Behring
- Grifols
- Octapharma
- Shire

Other prominent vendors
- ADMA Biologics
- Bayer
- Bharat Serum and Vaccines
- Biotest AG
- China Biologic Products
- Hualan Biological Engineering
- Kedrion Biopharma
- LFB Group
- Sanquin

Market driver
- Growing number of fractionating units
- For a full, detailed list, view our report

Market challenge
- Complex and cost-intensive manufacturing
- For a full, detailed list, view our report

Market trend
- Monetary support to plasma donors
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 70 pages "Global Intravenous Immunoglobulins Market 2017-2021" report covers Executive summary, Scope of the report, Research Methodology, Introduction, Market landscape, An overview of diseases treated using intravenous immunoglobulins, Pipeline landscape, Market segmentation by Therapy area, Geographical segmentation, Decision framework, Drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

For more information Visit at: http://www.drugpipeline.net/technavio/global-intravenous-immunoglobulins-market-2017-2021

Find all Pharma and Healthcare Reports at - http://www.drugpipeline.net/catalog/pharma-healthcare

Related Reports;

Global Urolithiasis Management Devices Market 2017-2021 - Visit at - http://www.drugpipeline.net/technavio/global-urolithiasis-management-devices-market-2017-2021

Global Tracheostomy Products Market 2017-2021 - Visit at - http://www.drugpipeline.net/technavio/global-tracheostomy-products-market-2017-2021

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.